This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
This article was written by Follow Andrew Hecht is a 35-year Wall Street veteran covering commodities and precious metals. He runs the investing group...
Alsea, S.A.B. de C.V. (OTCPK:ALSSF) Q2 2023 Earnings Call Transcript July 27, 2023 10:00 AM ET Company Participants Nicolás Espinoza Meneses – IR Armando...
Introduction TG Therapeutics, Inc. (NASDAQ:TGTX) develops and markets treatments for B-cell malignancies and autoimmune diseases. Their FDA-approved product, Briumvi, is a monoclonal antibody therapy...
Construction spending rose in June, as companies and the government increased projects across the U.S. Spending on construction projects rose 0.5% in June to...